ORIC 製藥公司
US ˙ NasdaqGS ˙ US68622P1093

SecurityORIC / ORIC Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership77,737 shares
Latest Disclosed Value $ 789,030
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 23.77% decrease in ownership of ORIC / ORIC Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 77,737 shares of ORIC Pharmaceuticals, Inc. (US:ORIC) valued at $789,031 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 101,980 shares of ORIC Pharmaceuticals, Inc.. This represents a change in shares of -23.77% during the quarter. The current value of the position is $583,028 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP ORIC Pharmaceuticals EC US68622P1093 77,737 -24,243 -23.77 789 38.66 0.0177
2025-05-28 2025-03-31 NP ORIC Pharmaceuticals EC US68622P1093 101,980 -4,261 -4.01 569 -33.61 0.0136
2025-02-25 2024-12-31 NP ORIC Pharmaceuticals EC US68622P1093 106,241 -16,521 -13.46 857 -31.88 0.0187
2024-11-26 2024-09-30 NP ORIC Pharmaceuticals EC US68622P1093 122,762 50,007 68.73 1,258 144.75 0.0238
2024-08-26 2024-06-30 NP ORIC Pharmaceuticals EC US68622P1093 72,755 3,846 5.58 514 -45.72 0.0105
2024-05-28 2024-03-31 NP ORIC Pharmaceuticals EC US68622P1093 68,909 -3,753 -5.17 947 41.77 0.0198
2024-02-26 2023-12-31 NP ORIC Pharmaceuticals EC US68622P1093 72,662 6,544 9.90 668 67.00 0.0143
2023-11-28 2023-09-30 NP ORIC Pharmaceuticals EC US68622P1093 66,118 0 0.00 400 -22.03 0.0104
2023-08-25 2023-06-30 NP ORIC Pharmaceuticals EC US68622P1093 66,118 17,897 37.11 513 99.61 0.0122
2022-05-26 2022-03-31 NP ORIC Pharmaceuticals EC US68622P1093 48,221 0 0.00 258 -63.70 0.0060
2022-02-25 2021-12-31 NP ORIC Pharmaceuticals EC US68622P1093 48,221 1,756 3.78 709 -27.09 0.0154
2021-11-24 2021-09-30 NP ORIC Pharmaceuticals EC US68622P1093 46,465 0 0.00 972 18.27 0.0214
2021-08-26 2021-06-30 NP ORIC Pharmaceuticals EC US68622P1093 46,465 12,333 36.13 822 -1.79 0.0176
2021-05-27 2021-03-31 NP ORIC Pharmaceuticals EC US68622P1093 34,132 0 0.00 836 -27.62 0.0190
2021-02-25 2020-12-31 NP ORIC Pharmaceuticals EC US68622P1093 34,132 19,428 132.13 1,155 214.71 0.0296
2020-11-25 2020-09-30 NP ORIC Pharmaceuticals EC US68622P1093 14,704 0 0.00 368 -25.86 0.0118
2020-08-27 2020-06-30 NP ORIC Pharmaceuticals EC US68622P1093 14,704 14,704 496 0.0162
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.